Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
Explore this paper's citation graph
- Type
- article
- Published
- 2019-05-23
- Cited by
- 1,985
- References
- 54
- Access
- Open access
- OpenAlex
- https://openalex.org/W2954124338
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:195766705
Keywords
Akkermansia muciniphila, Medicine, Internal medicine, Insulin resistance, Overweight
References
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- Specific gut microbiota features and metabolic markers in postmenopausal women with obesity
- Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
- Assay-dependent variability of serum insulin levels during oral glucose tolerance test: influence on reference intervals for insulin and on cut-off values for insulin sensitivity indices
- The Glucose and Lipid Effects of Colesevelam as Monotherapy in Drug-naïve Type 2 Diabetes
- Elevated white blood cell count in subjects with impaired glucose tolerance.
- Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- Influence of assay-dependent variability of serum insulin levels on insulin sensitivity indices
- Efficacy and tolerability of vildagliptin in drug‐naïve patients with type 2 diabetes and mild hyperglycaemia *
- Elevated endotoxin levels in non-alcoholic fatty liver disease
- Efficacy and Safety of Lobeglitazone Monotherapy in Patients with Type 2 Diabetes Mellitus over 24-Weeks: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial
- Consumption of plant sterol-enriched foods and effects on plasma plant sterol concentrations--a meta-analysis of randomized controlled studies.
- Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies
- Gamma‐glutamyl transpeptidase and the metabolic syndrome
- Use and abuse of HOMA modeling.
- Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.
- Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
- Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Cited by
- Gut Microbiota and Complications of Type-2 Diabetes
- Le transfert de microbiote fécal : quel potentiel thérapeutique dans le traitement des maladies métaboliques ?
- Precision medicine in Type 2 diabetes: Clinical markers of insulin resistance are associated with altered short and long-term glycemic response to DPP4-inhibitor therapy
- Bacteria to alleviate metabolic syndrome
- Gut Microbiome: Profound Implications for Diet and Disease
- Microbiota supplements to improve metabolic health
- Microbiota supplements to improve metabolic health
- Immune control of the microbiota prevents obesity
- Design of synthetic microbial consortia for gut microbiota modulation.
- The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity
- Modulation of Gut Microbiota for Health by Current and Next-Generation Probiotics
- Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome
- Microbiote intestinal, lipides alimentaires et maladies métaboliques
- Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
- Biological fates of tea polyphenols and their interactions with microbiota in the gastrointestinal tract: implications on health effects
- Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics
- New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes
- Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
- The gut microbiome and metabolic syndrome.
- Chitin–glucan and pomegranate polyphenols improve endothelial dysfunction
Related papers
- Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice
- Effect of Metformin on Metabolic Improvement and Gut Microbiota
- Dietary Polysaccharide from Enteromorpha Clathrata Modulates Gut Microbiota and Promotes the Growth of Akkermansia muciniphila, Bifidobacterium spp. and Lactobacillus spp.
- Dynamics of Structural and Functional Changes in Gut Microbiota during Treatment with a Microalgal β-Glucan, Paramylon and the Impact on Gut Inflammation
- Metformin and gut microbiota: their interactions and their impact on diabetes
- Metabolic consequences of alterations in gut microbiota induced by antidiabetic medications
- Non Alcoholic Fatty Liver Disease, Hepatic Insulin Resistance and Type 2 Diabetes
- Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans - towards treatment with probiotics.
- Effects of gut microbiota–derived extracellular vesicles on obesity and diabetes and their potential modulation through diet
- Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus